Company / PP&E (Net)
BioAge Labs, Inc. PP&E (Net) History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$963.0K
FY2025
5-year range
$323.0K / $963.0K
FY2023-FY2025
Trend
+62.9%
vs FY2024
Sector context
#159 of 193
Health Care
What the data says
BioAge Labs, Inc.'s pp&e (net) of $963,000 is lower than 82% of companies in the Health Care sector (FY2025). Improved from $323,000 to $963,000 over the past 2 years.
Based on SEC 10-K filings.
$963,000 in FY2025.
Improved from $323,000 to $963,000 over the past 2 years.
Health Care sector context is included.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 18% in Health CareTop 82% of 193This company $963.0K Sector average $777.6M
▼
-99.9% below sector average
Key checks
Key Insights
- In FY2025, pp&e (net) increased 62.9% year-over-year.
- Ranks #159 out of 193 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.75 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $963.0K | +62.9% |
| FY2024 | $591.0K | +83.0% |
| FY2023 | $323.0K | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026